Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL193101 | 0.95 | — | — | |
| SCHEMBL29502859 | 0.92 | — | — | |
| SCHEMBL1263638 | 0.86 | ALDH1A1 (0.47) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL6609352 | 0.86 | ALDH1A1 (0.47) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL15412364 | 0.86 | ALDH1A1 (0.47) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL1727052 | 0.86 | ALDH1A1 (0.47) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL4472844 | 0.85 | ALDH1A1 (0.35) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL19881234 | 0.85 | TSHR (0.46) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL20348278 | 0.84 | TSHR (0.43) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL21781858 | 0.84 | TSHR (0.43) | ALDH1A1TSHRTDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114502567-A | Method for producing glycoside compound | 住友化学株式会社 | 2022-05-13 | — | — | CN | disclosed |
| CN-101842473-B | Novel nitrile and amidoxime compounds and methods of preparation | EKC TECHNOLOGY INC | 2013-02-13 | — | — | CN | disclosed |
| US-8062429-B2 | Methods of cleaning semiconductor devices at the back end of line using amidoxime compositions | EKC TECHNOLOGY, INC. (US) | 2011-11-22 | — | — | US | disclosed |
| US-8062429-B2 | Methods of cleaning semiconductor devices at the back end of line using amidoxime compositions | EKC TECHNOLOGY, INC. (US) | 2011-11-22 | — | — | US | disclosed |
| US-8062429-B2 | Methods of cleaning semiconductor devices at the back end of line using amidoxime compositions | EKC TECHNOLOGY, INC. (US) | 2011-11-22 | — | — | US | disclosed |
| CN-101910057-A | Stabilization of hydroxylamine containing solutions and method for their preparation | EKC TECHNOLOGY INC | 2010-12-08 | — | — | CN | disclosed |
| US-7838483-B2 | Process of purification of amidoxime containing cleaning solutions and their use | EKC TECHNOLOGY, INC. (US) | 2010-11-23 | — | — | US | disclosed |
| US-7838483-B2 | Process of purification of amidoxime containing cleaning solutions and their use | EKC TECHNOLOGY, INC. (US) | 2010-11-23 | — | — | US | disclosed |
| US-7838483-B2 | Process of purification of amidoxime containing cleaning solutions and their use | EKC TECHNOLOGY, INC. (US) | 2010-11-23 | — | — | US | disclosed |
| CN-101842473-A | Novel nitrile and amidoxime compounds and methods of preparation | EKC TECHNOLOGY INC | 2010-09-22 | — | — | CN | disclosed |
| WO-2009058274-A1 | CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE | EKC TECHNOLOGY, INC. (US) | 2009-05-07 | — | — | WO | disclosed |
| WO-2009058274-A1 | CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE | EKC TECHNOLOGY, INC. (US) | 2009-05-07 | — | — | WO | disclosed |
| WO-2009058273-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | EKC TECHNOLOGY, INC. (US) | 2009-05-07 | — | — | WO | disclosed |
| WO-2009058278-A1 | METHODS OF CLEANING SEMICONDUCTOR DEVICES AT THE BACK END OF LINE USING AMIDOXIME COMPOSITIONS | EKC TECHNOLOGY, INC (US) | 2009-05-07 | — | — | WO | disclosed |
| US-20090112024-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | EKC TECHNOLOGY, INC. | 2009-04-30 | — | — | US | disclosed |
| US-20090112024-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | EKC TECHNOLOGY, INC. | 2009-04-30 | — | — | US | disclosed |
| US-20090112024-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | EKC TECHNOLOGY, INC. | 2009-04-30 | — | — | US | disclosed |
| US-20090111965-A1 | NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION | EKC TECHNOLOGY, INC. | 2009-04-30 | — | — | US | disclosed |
| US-20090111965-A1 | NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION | EKC TECHNOLOGY, INC. | 2009-04-30 | — | — | US | disclosed |
| US-20090111965-A1 | NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION | EKC TECHNOLOGY, INC. | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112024-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | HNMT, HMOX2, EGLN2 | ALDH1A1 801/4885TSHR 1663/4885TDP1 1225/4885 |
| US-20090111965-A1 | NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION | GNMT, NIT2, NNMT | ALDH1A1 3167/4885TSHR 3860/4885TDP1 1699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.